# Delayed Release Diclofenac Sodium Formulation vs Voltaren®

> **NCT02714842** · PHASE1 · COMPLETED · sponsor: **BDD Pharma Ltd** · enrollment: 36 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Radiolabelled Diclofenac Tablet A
- **DRUG:** Radiolabelled Diclofenac tablet B
- **DRUG:** Radiolabelled Diclofenac tablet C
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT02714842
- **Lead sponsor:** BDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714842, "Delayed Release Diclofenac Sodium Formulation vs Voltaren®". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02714842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*